Furthermore, canine OSA cell lines were found to express high levels of BMI1 protein, and siRNA mediated BMI1 knockdown or small molecule BMI1 inhibition in canine OSA cells results in a reduction in cellular proliferation and an increased sensitivity to the chemotherapeutic drugs carboplatin and doxorubicin. Here, BMI1 is linked to obstructive sleep apnea syndrome.